|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,477 INR | -1.33% |
|
+0.71% | +18.51% |
| May. 31 | Cipla's Global Chief Technology Officer Retires | MT |
| May. 30 | India's pharma export sales to grow faster this year, trade body says | RE |
BENGALURU (Reuters) - Indian drugmaker Cipla said on Friday its U.S. unit was recalling six batches of Albuterol Sulfate Inhalation Aerosol due to a "container defect".
(Reporting by Nishit Navin; Editing by Krishna Chandra Eluri)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,754 PTS | -0.12% | -0.66% | - | ||
| 1,477 INR | -1.33% | +0.71% | 14.49B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +18.51% | 14.49B | |
| +16.93% | 42.79B | |
| +22.25% | 22.81B | |
| +16.96% | 15.04B | |
| +51.63% | 12.65B | |
| -0.05% | 6.79B | |
| -11.65% | 6.74B | |
| -8.87% | 5.73B | |
| +14.27% | 5.47B | |
| +6.91% | 4.76B |
CIPLA LIMITED 
